International researchers are using molecular profiling to identify different types of pleural mesothelioma tumors, according to an October 2019 study. These profiles allow doctors to distinguish tumors that otherwise look very similar under a microscope, which is essential to making a correct diagnosis and administering the most effective treatments. New Findings May Help Malignant Pleural
Chemoimmunotherapy may kill cancer cells more quickly while decreasing the negative effects of chemotherapy. This could result in increased survival rates for mesothelioma patients, who often struggle to live past one or two years following their diagnosis. Chemoimmunotherapy drugs may be the “next frontier” in treating mesothelioma. What Is Chemoimmunotherapy? Chemoimmunotherapy is a promising treatment
Photo Credit: 2019 Novocure. All rights reserved. The U.S. Food & Drug Administration (FDA) recently approved a breakthrough treatment option for malignant pleural mesothelioma patients. Novocure’s NovoTTF-100L offers new hope, with clinical trials improving the prognosis of patients who used it with chemotherapy. It is the first new treatment option for the deadly disease to
At a recent International Symposium on Malignant Mesothelioma, three doctors representing some of the biggest organizations behind mesothelioma treatment discussed what patients should look for to determine a truly outstanding mesothelioma treatment center. The quality of the center you choose for your care may determine your treatment options, your prognosis, and overall, your quality of
On April 18, 2019, Harpoon Therapeutics, Inc. announced the dosing of their first patient with HPN536. HPN536 is a type of lab-created protein that causes T cells — special cells in the immune system — to target and attack mesothelioma and other cancer cells. Part 2 of the clinical trial will involve volunteers with mesothelioma.
September 26, 2019 marks the 16th annual Mesothelioma Awareness Day. Since 2004, the Mesothelioma Applied Research Foundation (Meso Foundation) has spearheaded Mesothelioma Awareness Day to drive more attention and funding toward mesothelioma treatment research. For over a decade and a half, the thousands of participants in Mesothelioma Awareness Day have helped more and more families
Managing mesothelioma pain during treatment is a challenge because pain is often caused by multiple factors. However, the more experts understand the pathology of pain—how and why pain develops—the more effectively they can treat it and improve patient quality of life. A new oncology nurses’ report looked at the challenges doctors face when trying to
A cancer diagnosis, like mesothelioma, causes severe emotional distress producing a range of symptoms and mental health issues. Mesothelioma patients should be aware of the prevalent issue of mental health and cancer and understand what emotional issues may arise after diagnosis and throughout treatment. Learning you have cancer is a highly emotional and stressful time.
A new study shows that aggressive radiation for pleural mesothelioma may be a crucial treatment option that improves patients’ life expectancy. The results from the research showed that pleural mesothelioma patients who undergo high doses of chest radiation have extended survival. About Radiation for Pleural Mesothelioma Currently, treatment options for pleural mesothelioma are limited and
Researchers may have confirmed a quick, effective and minimally invasive tumor tracking test for pleural mesothelioma. A simple blood test may soon accompany the standard CT scans to accurately detect tumors and allow doctors to quickly respond with appropriate treatments. Mesothelin Testing in Mesothelioma Patients Researchers have been investigating the connection between mesothelin blood levels